Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telithromycin vs azithromycin vs cefuroxime axetil in acute exacerbation of chronic bronchitis
2004-001412-30Phase 4Completed
- Sponsor
- Sanofi
- Start
- Sep 2005
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of telithromycin in chronic bronchitis (CB) (3 arms), sponsored by Sanofi. Primary endpoint: Presence of persistent resistant Streptococcus pneumoniae in sputum at Test of Cure. Started Sep 2005; status: completed.
02
Drugs
telithromycin
03
Conditions
chronic bronchitis (CB)
Beyond the preview
Go deeper on 2004-001412-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001412-30.